Akreos AO microincision lens and Amaris excimer laser win Medical Design Excellence Awards

Article

The Akreos AO microincision lens (model MI60; Bausch and Lomb) and the Amaris excimer laser (Schwind) have been named amongst 33 winners at the 2008 Medical Design Excellence Awards (MDEA).

The Akreos AO microincision lens (model MI60; Bausch and Lomb) and the Amaris excimer laser (Schwind) have been named amongst 33 winners at the 2008 Medical Design Excellence Awards (MDEA).

The Akreos MI60 intraocular lens is acrylic and designed for implantation through a 1.8 mm incision. The supply and design of the IOL has been credited to Contamac (Saffron Walden, UK), Complices (Toulouse, France), and Medicel (Widnau, Switzerland).

The Amaris excimer laser is designed to correct ametropia and corneal changes. It features a 1,050 Hz turbo eye tracker (5 D eye tracker), with a response time of less than three milliseconds. According to Schwind, one diopter of correction takes on average less than 2.5 seconds, whilst the small beam diameter of 0.54 mm (FWHM) allows maximum precision and smooth treatment surfaces. The supply and design of the laser has been credited to SMI (Berlin, Germany).

The awards will be presented on Wednesday, June 4, 2008 in a ceremony at the Medical Design & Manufacturing (MD&M) East 2008 Conference and Exposition in New York City, US.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.